[1]
“The Impact of Chimeric Antigen Receptor (CAR) T Cell Therapy: Its Potential to Reshape Rheumatology Practice”, Can Rheumatol Today, vol. 2, no. 1, pp. 30–36, Jun. 2025, doi: 10.58931/crt.2025.2160.